AMICUS THERAPEUTICS, INC. Uncategorized Contracts & Agreements

62 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Second Restated Agreement, dated November 19, 2013 by and between the Registrant and Glaxo Group Limited
AMICUS THERAPEUTICS, INC.
Biotechnology
DE
2024
Amendment #3 to the Amicus Therapeutics, Inc. Cash Deferral Plan
AMICUS THERAPEUTICS, INC.
Biotechnology
2021
Description of the Registrant's securities
AMICUS THERAPEUTICS, INC.
Biotechnology
2020
Amendment #2 to the Amicus Therapeutics, Inc. Cash Deferral Plan
AMICUS THERAPEUTICS, INC.
Biotechnology
2019
JPMorgan Chase Bank, National Association Organised under the laws of the United States as a National Banking Association. Main Office 1111 Polaris Parkway, Columbus, Ohio 43240...
AMICUS THERAPEUTICS, INC.
Biotechnology
NY
2016
GOLDMAN, SACHS & CO. | 200 WEST STREET | NEW YORK, NEW YORK 10282-2198 | TEL: 212 ###-###-####
AMICUS THERAPEUTICS, INC.
Biotechnology
NY
2016
JPMorgan Chase Bank, National Association Organised under the laws of the United States as a National Banking Association. Main Office 1111 Polaris Parkway, Columbus, Ohio 43240...
AMICUS THERAPEUTICS, INC.
Biotechnology
NY
2016
GOLDMAN, SACHS & CO. | 200 WEST STREET | NEW YORK, NEW YORK 10282-2198 | TEL: 212 ###-###-####
AMICUS THERAPEUTICS, INC.
Biotechnology
NY
2016
AMICUS THERAPEUTICS, INC. CASH DEFERRAL PLAN
AMICUS THERAPEUTICS, INC.
Biotechnology
2016
1 Cedarbrook Drive, Cranbury, NJ 08512 ###-###-#### www.amicusrx.com
AMICUS THERAPEUTICS, INC.
Biotechnology
2016
AMENDMENT NO. 1 TO THE AMICUS THERAPEUTICS, INC. CASH DEFERRAL PLAN
AMICUS THERAPEUTICS, INC.
Biotechnology
2014
LETTER AGREEMENT
AMICUS THERAPEUTICS, INC.
Biotechnology
2014
LETTER AGREEMENT
AMICUS THERAPEUTICS, INC.
Biotechnology
2014
AMICUS THERAPEUTICS, INC. CASH DEFERRAL PLAN
AMICUS THERAPEUTICS, INC.
Biotechnology
2014
LETTER AGREEMENT
AMICUS THERAPEUTICS, INC.
Biotechnology
2014
LETTER AGREEMENT
AMICUS THERAPEUTICS, INC.
Biotechnology
2014
SECOND RESTATED AGREEMENT
AMICUS THERAPEUTICS, INC.
Biotechnology
DE
2014
LETTER AGREEMENT
AMICUS THERAPEUTICS, INC.
Biotechnology
2013
LETTER AGREEMENT
AMICUS THERAPEUTICS, INC.
Biotechnology
2013
LETTER AGREEMENT
AMICUS THERAPEUTICS, INC.
Biotechnology
2013
1 Cedar Brook Drive Cranbury, NJ 08512 T: 609 ###-###-#### F: 609 ###-###-#### www.amicusrx.com
AMICUS THERAPEUTICS, INC.
Biotechnology
2013
1 Cedar Brook Drive Cranbury, NJ 08512 T: 609 ###-###-#### F: 609 ###-###-#### www.amicusrx.com
AMICUS THERAPEUTICS, INC.
Biotechnology
2013
1 Cedar Brook Drive Cranbury, NJ 08512 T: 609 ###-###-#### F: 609 ###-###-#### www.amicusrx.com
AMICUS THERAPEUTICS, INC.
Biotechnology
2013
/s/ William D. Baird
AMICUS THERAPEUTICS, INC.
Biotechnology
2012
L E A S E A G R E E M E N T
AMICUS THERAPEUTICS, INC.
Biotechnology
2011
LETTER AGREEMENT
AMICUS THERAPEUTICS, INC.
Biotechnology
2011
the progress and results of our clinical trials of our drug candidates, including Amigal
AMICUS THERAPEUTICS, INC.
Biotechnology
2011
the progress and results of our clinical trials of our drug candidates, including Amigal
AMICUS THERAPEUTICS, INC.
Biotechnology
2011
the progress and results of our clinical trials of our drug candidates, including Amigal
AMICUS THERAPEUTICS, INC.
Biotechnology
2011
the progress and results of our clinical trials of our drug candidates, including Amigal
AMICUS THERAPEUTICS, INC.
Biotechnology
DE
2011
the progress and results of our clinical trials of our drug candidates, including Amigal
AMICUS THERAPEUTICS, INC.
Biotechnology
DE
2011
AMENDED AND RESTATED AMICUS THERAPEUTICS 2007 DIRECTOR OPTION PLAN
AMICUS THERAPEUTICS, INC.
Biotechnology
NJ
2010
the progress and results of our clinical trials of our drug candidates, including Amigal
AMICUS THERAPEUTICS, INC.
Biotechnology
2010
Form of
AMICUS THERAPEUTICS, INC.
Biotechnology
DE
2010
our plans to develop, seek regulatory approval for and commercialize Amigal, Plicera and AT2220
AMICUS THERAPEUTICS, INC.
Biotechnology
2009
our plans to develop, seek regulatory approval for and commercialize Amigal, Plicera and AT2220
AMICUS THERAPEUTICS, INC.
Biotechnology
2009
our plans to develop, seek regulatory approval for and commercialize Amigal, Plicera and AT2220
AMICUS THERAPEUTICS, INC.
Biotechnology
2009
our plans to develop, seek regulatory approval for and commercialize Amigal, Plicera and AT2220
AMICUS THERAPEUTICS, INC.
Biotechnology
2009
our plans to develop, seek regulatory approval for and commercialize Amigal, Plicera and AT2220
AMICUS THERAPEUTICS, INC.
Biotechnology
2009
our plans to develop, seek regulatory approval for and commercialize Amigal, Plicera and AT2220
AMICUS THERAPEUTICS, INC.
Biotechnology
2009